SCYNEXIS : 10-K Filing | MarketScreener
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ... | March 31, 2023
Source: marketscreener.com
Ivor Macleod News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Ivor Macleod. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Ivor Macleod Today - Breaking & Trending Today
SCYNEXIS, Inc. (SCYX) Q3 2022 Earnings Call Transcript
SCYNEXIS, Inc. (NASDAQ:NASDAQ:SCYX) Q3 2022 Results Conference Call November 9, 2022 08:30 AM ET Company Participants Debbie Etchison - Communications & IR Dr.
Source: seekingalpha.com
Biopharma Veteran Ivor Macleod Joins SCYNEXIS as Chief Financial Officer
25.10.2022 - Brings deep industry experience spanning financial and operational roles to support Company and its new strategic directionJERSEY CITY, N.J., Oct. 25, 2022 (GLOBE NEWSWIRE) - SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering ... Seite 1
Source: wallstreet-online.de
SCYNEXIS Provides Corporate, Commercial and R&D Strategy Updates to Expand Market Potential for Its First-in-Class Antifungal
20.10.2022 - SCYNEXIS is announcing a new strategic direction to refocus its resources on the clinical development of ibrexafungerp for severe, hospital-based indications in which higher long-term returns are expected, given the promising data generated to date ... Seite 1
Source: wallstreet-online.de
Athersys names interim chief financial officer
The Cleveland-based regenerative medicine company announced Thursday, Aug. 4, that it has named turnaround consultant Kasey Rosado to the interim CFO role. Ivor Macleod, the company's former CFO, left Athersys on June 30 as part of a restructuring announced in early June that is cutting the workforce by 70%.
Source: crainscleveland.com